Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T20:04:38.305Z.
Consensus retrieved: 2026-10-06T17:16:06.672Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T20:04:38.305Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1639651ea08d8a43111aa8341d4d68762a5dc33ecadd1da8a92c037613eb041e
Forward PE Ratio (N/A) = Dated Quote Price ($6.88) / Consensus Forward EPS ($-1.17)
FORWARD PE RATIO
N/A
Instil Bio, Inc.
Market Cap
$46.69M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Instil Bio, Inc. (TIL) | $46.69M | N/A |
| Apollomics, Inc. (APLM)vs › | $47.59M | N/A |
| Celularity Inc. (CELU)vs › | $45.73M | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | N/A |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | N/A |
| TELA Bio, Inc. (TELA)vs › | $48.77M | N/A |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | N/A |
| DarioHealth Corp. (DRIO)vs › | $44.49M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $6.88, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-1.17 | $-1.17 – $-1.17 | 1 | n/m |
| 2027-12-31 | $-8.28 | $-8.28 – $-8.28 | 1 | n/m |
| 2028-12-31 | $-11.06 | $-11.06 – $-11.06 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
